Clinical Trial Update: Dose Reduction in Thoracic CT [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 trial evaluating dose reduction in thoracic CT for lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lymphoma | Phase 1 | Status: COMPLETED